PNIBLOG

The Many Manifestations of Meningioma

Meningiomas, the most common primary brain tumor, can arise literally anywhere in the intracranial dura – the thick membrane that surrounds the brain – and even inside the fluid filled chambers of the brain. Neurosurgeons need to have a full surgical armamentarium for their removal, ideally using keyhole techniques that maximize tumor removal and minimize risk of collateral damage and complications. Read about Pacific Neuroscience Institute’s extensive meningioma experience.

Clinical Trials Round-Up at PNI

Find out about the latest clinical trials at Pacific Neuroscience Institute for brain tumor, stroke and other neurological areas. Call our center at 310-829-8265 to enroll.

Early detection of brain cancer

By the time patients start getting treated for brain cancer, their prognosis is often very poor, with an average survival of 14 months. Find out how early detection of cancers is emerging as a promising field of exploration.

CerebraCell aparatus

Imagine using electricity to non-invasively treat and cure brain cancer. Or stroke. Or Parkinson’s. Or an aneurysm. Or Alzheimer’s, depression, concussion. Dr. Santosh Kesari is a physician scientist who sees the possibilities in the world of alternating electric field therapy.

ONS Members Share Resources, Experiences With Philippine Colleagues

Cancers are never confined by borders. For most disease types, the ones seen in clinics and institutions throughout the United States are the same found in other first-, second-, and third-world countries. The realities facing cancer, treatments, and patient outcomes are often challenging to address no matter where you live, and it’s one of the many common threads that tie oncology professionals together the world over. Read about the unique challenges faced in The Philippines.

Airflight safety for Brain Tumor Patients

Thanks to the ever-increasing availability of medical information available online and capabilities for long distance tele-health consultations, patients have many options to undergo multidisciplinary treatment for their conditions with experts worldwide. Find out if it is safe for patients with brain tumors to fly.

Boston Biomedical Wizard201G Trial at Pacific Neuroscience Institute

The Wizard201G clinical trial from Boston Biomedical Inc. is a vaccine treatment for patients with recurrent or progressive GBM following initial treatment. Pacific Neuroscience Institute is a site for this phase 2 study which is currently recruiting. Contact us for eligibility criteria at 310-582-7460.